NCT02360852View on ClinicalTrials.gov

IBAT Inhibitor A4250 for Cholestatic Pruritus

PHASE2TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Biliary Cirrhosis, Primary

Interventions

DRUG

A4250

A4250 once daily

Trial Locations (1)

Unknown

Sahlgrenska Academy, Gothenburg

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Albireo

INDUSTRY

lead

Sahlgrenska University Hospital

OTHER